HİPOKSİ İLE OLUŞTURULAN MYOKARDİYAL HASAR ÜZERİNE MELATONİNİN ETKİSİ
Sunulan çalışmada hipoksik hasarın etyopatogenezinde yer alan serbest radikallerin, lipid peroksidasyon ürünlerinin ve antioksidan enzimlerin rolünü değerlendirmek amaçlanmıştır. Çalışmada deney hayvanı olarak tavşan kullanıldı. Tavşanlar; Grup I: Hipoksi grubu (n=9), Grup II: Hipoksi+Melatonin grubu (n=9), Grup III: Kontrol grubu (n=7) olmak üzere üç gruba ayrıldılar. Hipoksi oluşturulmadan önce bazal serum troponin I, kreatin kinaz–MB (CKMB), laktat dehidrojenaz (LDH), plazma glutatyon peroksidaz (GSH-Px), süperoksit dismutaz (SOD), malondialdehit (MDA) ve nitrik oksit (NO) düzeyleri için kan alındı. Grup I, II’ deki deney hayvanları bir fanus içerisinde 5 lt/10 dk akımla %10 oksijen-azot karışımına maruz bırakılarak hipoksi oluşturuldu. İkinci grupta hipoksi oluşturulduktan sonra 5 gün süreyle melatonin (10 mg/kg/gün intraperitoneal) verildi. Tedavi sonunda serum CKMB, LDH ve troponin I, plazma NO, MDA, SOD ve GSH-Px düzeyleri çalışıldı. Tavşanlar sakrifiye edilip myokardiyal NO, MDA, SOD, GSH-Px düzeyleri çalışıldı ve histopatolojik olarak myokard dokusu Hemotoksilen-Eozin boyama ile değerlendirildi. Hipoksi oluşturulan birinci grup, tavşanlarda serum CKMB, LDH, troponin I düzeylerinde artış, plazma SOD’de, GSH-Px’da azalma ve histopatolojik olarak miyokard liflerinde şişme, intertisiyel ödem, disorganizasyon ve nekrozdan oluşan ağır kardiyomyopati tesbit edildi. Hipoksi+ Melatonin uygulanan grupta; plazma SOD düzeylerinde anlamlı artış, doku NO ve MDA düzeylerinde anlamlı düşme tesbit edildi. Histopatolojik incelemede, melatonin grubunda; miyokard liflerinde şişme, intertisiyel ödem ve disorganizasyondan oluşan hafif-orta kardiyomyopati tesbit edildi. Sonuç olarak; melatoninin antioksidan etkinlik sağlayarak hipoksiye bağlı kardiyak hasarı önleyebileceği kanısına varıldı
Effects of Melatonin on the Myocardial Damage, Induced by Hypoxia
The aim of this study was to evaluate the role of antioxidant enyzmes, lipid peroxidation products and free radicals which involve in the etiopathogenesis of the hypoxic damage. The experimental animals were assigned to 5 groups. Group 1: Hypoxia group (n=9), Group II: Hypoxia + melatonin group (n=9), Group III: Control group (n=7). Blood was taken for analysing the levels of basal serum troponin I, creatine kinase-MB (CKMB), lactate dehydrogenase(LDH), plasma glutation peroxidase (GSH-Px), superoxide dismutase (SOD), malondialdehyde (MDA) and nitric oxide (NO) before inducing the hypoxia. In the experimental animals of groups I, II, the hypoxia was induced by leaving the animals to breathe in belljar, containing 10 per cent oxygen-nitrogen mixture, for 10 minutes at 5 liter velocity. After inducing the hypoxia melatonin (10 mg/kg/daily & intraperitoneal) was administered to the animals of second group during 5 days. The levels of serum CKMB, LDH and troponin I, plasma NO, MDA, SOD and GSHPx were analysed at the end of the treatment. After sacrificing the experimental animals, tle levels of myocardial NO, MDA, SOD, GSH-Px were analysed and myocardial tissue was examined histopathologically with haematoxylin - eosin stain. The levels of serum-CMKB, LDH and troponin I were found increased; whereas the levels of plasma SOD and GSH-Px were found decreased in the hypoxia-induced group and a heavy cardiomyopathy associated with swelling in myocardial flaments, interstitial edema, disorganization and necrosis was determined. There was a meaningful increase in the levels of plasma SOD but a meaningful decrease in the levels of tissue NO and MDA and a mild and intermediate cardiomyopathy associated with swelling, interstitial edema and disorganization was shown histopathologically in the second group (hypoxia and melatonin). It is shown that the melatonin can protect the hypoxic cardiac damage by being activated as an antioxidant
___
- 1. Haider KH, Stimson WH. Cardiac
myofibrillar proteins: biochemical markers to
estimate myocardial injury. Mol Cell Biochem
1999,194:31-39.
- 2. Dhalla NS, Elmoselhi AB, Hata T, Makino N.
Status of myocardial antioxidants in
ischemia-reperfusion injury. Cardivasc
Res.2000,47:446-456.
- 3. Das UN. Free radicals , cytokines and nitric
oxide in cardiac failure and myocardial
infarction. Mol Cell Biochem 2000,215:145-
152.
- 4. Halliwell B. Free radicals and antioxidants: a
personal view.Nutr Rev. 1994;52:253-265.
- 5. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions
of melatonin in the reduction of oxidative
stress. A review. J Biomed Sci 2000,7:444-
458.
- 6. Reiter RJ, Carnerio RC. Melatonin in relation
to cellular antioxidative defense mechanisms.
Horm Metab Res 1997,29:363-372.
- 7. Duncker DJ, Verdouw PD. Has melatonin a
future as a cardioprotective agent?
Cardiovasc Drugs Ther 2001,15:205-207.
- 8. Rumsey WL, Abbott B, Bertelsen D et al.
Adaptation to hypoxia alters enegy
metabolism in rat heart. Am J Physiol
1999,276:71-80.
- 9. Paglia DE, Valentina WN. Studies on the
quantitavive and qualitative characterization
of erythrocyte glutathione peroxidase. J Lab
Clin Med 1967,70:158-169.
- 10. Sun Y, Oberley LW, Li Y. A simple method for
clinical assay of superoxide dismutase. Clin
Chem 1988,3413:497-500.
- 11. Jain SK. Evidence for membrane lipid
peroxidation during the in vivo aging of
human erytrocytes. Biochem Biophys Acta
1988,937:205-210.
- 12. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbutiric
acid relations. Analytical Biochemistry
1979, 95:351-358.
- 13. Davidge ST, Stranko CP, Roberts JM. Urine
but not plasma nitric oxide metabolites are
decreased in women with preeclampsia. Am
J Obstet Gynecol 1996,174:1008-1013.
- 14. Moshage H, Kok B, Huizenga JR, Jansen
PL. Nitrite and nitrate determinations in
plasma: a critical evaluation.Clin Chem
1995,41:892-896.
- 15. Morishima I, Matsui H, Mukawa H, Hayashi
K, Toki Y, Okumura K, Ito T, Hayakawa T.
Melatonin, a pineal hormone with
antioxidant property, protects against
adriamycin cardiomyopathy in rats. Life Sci
1998,63:511-521.
- 16. Foex P. Myocardial ischaemia. Clin Anaesth
1999,13:321-334.
- 17. Jaffe AS, Landt Y, Parvin CA, et al.
Comparative sensitivity of cardiac troponin I
and lactate dehydrogenase isoenzymes for
diagnosing acute myocardial infarction.
Clinical Chemistry 1996, 42:1770-1776.
- 18. Chiu A, Chan WK, Cheng SH, Leung CK,
Choi CH. Troponin-I, myoglobin, and mass
concentration of creatine kinase-MB in acute
myocardial infarction. J Med 1999,92: 711-
718.
- 19. Vorderwinkler KP, Mair J, Puschendorf B,
Hempel A, Schlüter K.D, Piper H.M.
Cardiac troponin I increases in parallel to
cardiac troponin T ,creatine kinase and
lactate dehydrogenase in effluents from
isolated perfused rat hearts after hypoxiareoxygenation-induced myocardial injury.
Clinica Chimica Acta 1996,251:113-117.X
- 20. Remppis A, Scheffold T, Greten J et al.
Intracellular compartmentation of troponin
T: release kinetics after global ischemia and
calcium paradox in the isolated perfused rat
heart. J Mol Cell Cardiol 1995,27: 793-803.
- 21. Asayama J, Yamahara Y, Otha B, et al.
Release kinetics of cardiac troponin T in
coronary effluent from isolated rat hearts
during hypoxia and reoxygenation. Basic Res
Cardiol 1992,87:428-436.
- 22. Bleier J, Vorderwinkler KP, Falkensammer J
e t a l . D i f f e r e n t i n t r a c e l l u l a r
compartmentations of cardiac troponins and
myosin heavy chains: a causal connection to
their different early release after myocardial
damage. Clin Chem 1998,44(9):1912-1918.
- 23. Ferrari R, Ceconi C, Curello S, et al. Role of
oxygen free radicals in ischemic and
reperfused myocardium. J Clin Nutr 1991,53:
215-222.
- 24. Rao PS, Cohen MV, Mueller HS. Production
of free radicals and lipid peroxides in early
experimental myocardial ischemia. J Mol Cell
Cardiol 1983,15:713-716.
- 25. Depre C, Fierain L, Hue L. Activation of
nitric oxide synthase by ischaemia in the
perfused heart. Cardiovasc Res 1997,33: 82–
87.
- 26. Wang PH, Zweier JL. Measurement of nitric
oxide and peroxynitrite generation in the
postischemic heart: evidence for
peroxynitrite-mediated reperfusion injury. J
Biol Chem 1996,2 71: 29223–29230.
- 27. Guarnieri C, Flamigni F, Caldarera CM. Role
of oxygen in the cellular damage induced by
re-oxygenation of hypoxic heart.J Mol Cell
Cardiol 1980 ,12: 797-808.
- 28. Kihlström M, Kainulainen H, Salminen A.
Enzymatic and nonenzymatic lipid
peroxidation capacities and antioxidants in
hypoxic and reoxygenated rat myocardium.
Exp Mol Pathol 1989;50:230-238.
- 29. Arduini A, Mezzetti A, Porreca E et al. Effect
of ischemia and reperfusion on antioxidant
enzymes and mitochondrial inner membrane
proteins in perfused rat heart. Biochim
Biophys Acta 1988,970:113-121.
- 30. Yuan SM. Cytochemistry and ultrastructure
of canine myocardium undergoing global
ischemia and reperfusion injury. J Med Sci
1999,15(1):1-7.
- 31. Reiter R, Tang L, Garcia JJ, Munoz-Hoyos
A. Pharmacological actions of melatonin in
oxygen radical pathophysıology. Life Sci
1997,60:2255-2271
- 32. Kaneko S, Okumuro K, Numaguchi Y, et al.
Melatonin scavenges hydroxyl radical and
protects isolated rat heart from ischemic
reperfusion injury. Life Sci 2000,67:101-
112.
- 33. Gilad E, Cuzzocrea S, Zingarelli B,
Salzman AL, Szabo C. Melatonin is a
scavenger of peroxynitrite. Life Sci
1997,60:169-174.
- 34. Szarszoi O, Asemu G, Vanecek J, Ostadal
B, Kolar F.Effects of melatonin on
ischemia and reperfusion injury of the rat
heart. Cardiovasc Drugs Ther 2001,15:
251-257.
- 35. Sahna E, Acet A, Ozer MK, Olmez E.
Myocardial ischemia-reperfusion in rats:
reduction of infarct size by either
sup ple me nta l p hys i olo gic al or
pharmacological doses of melatonin. J
Pineal Res 2002,33: 234-238.